Takeda and its partner network are committed to improving patient care through support of scientific advances in medicine and increasing understanding of important diseases. As part of this commitment, the Investigator-Initiated Sponsored Research (IISR) program supports innovative clinical and basic science studies that address important medical and scientific questions related to our compounds and therapeutic areas of interest.
IISR is defined as unsolicited, independent research where the investigator or the institution (academic, private, or governmental) serves as the Sponsor and Takeda provides support in the form of study drug and/or funding.
IISR proposals are reviewed by Takeda medical and scientific personnel. Decisions are based upon scientific merit as well as alignment with research areas of interest and availability of resources.
Support for an IISR is awarded strictly based on research merit criteria. Support of a study in no way implies any obligation toward or is any way connected to the recommendation or prescribing of Takeda products.
We appreciate your interest in the Takeda IISR program.